Physician profile
Chand Rohatgi
NPI 1457438178
$9,165.93
in general payments reported to CMS, 2019-2025
20 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $1,951 · 2021: $2,202 · 2022: $645 · 2023: $122 · 2024: $1,237 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Travel and Lodging: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.02 |
| Travel and Lodging | $1,371.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $2,963.28 | 2022-2025 | |
| Stryker Corporation | $1,955.72 | 2021 | |
| Heron Therapeutics, INC. | $1,500.00 | 2020 | |
| Medtronic USA, INC. | $1,236.44 | 2019 | |
| Intuitive Surgical, INC. | $446.47 | 2020-2025 | |
| Myriad Genetic Laboratories, INC. | $255.96 | 2021-2025 | Myrisk |
| Davol INC. | $148.04 | 2024 | Arista Ah Flexitip |
| Merck Sharp & Dohme LLC | $122.16 | 2023 | Keytruda |
| Genzyme Corporation | $120.00 | 2019 | |
| Roche Diagnostics Corporation | $101.55 | 2019 | |
| Eisai INC. | $98.13 | 2019 | |
| Dilon Technologies, INC. | $46.22 | 2020 | |
| Gilead Sciences, INC. | $31.75 | 2024 | |
| Solventum Corporation | $28.82 | 2025 | V.A.C. Veraflo, Prevena Restor Bellaform, Prevena |
| Smith+Nephew, INC. | $27.66 | 2024 | Renasys Touch |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $22.92 | 2025 | Xt Cdx |
| Esperion Therapeutics, INC. | $17.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.04 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chand Rohatgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.